Stay updated with breaking news from Bluejay Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) is one of 216 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its rivals? We will compare Bluejay Diagnostics to similar businesses based on the strength of its analyst recommendations, earnings, valuation, dividends, profitability, institutional ownership and risk. Analyst Ratings This is […]
ACTON, Mass., July 26, 2022 -- Bluejay Diagnostics, Inc. , a medical diagnostics company focused on developing cost-effective, rapid, near-patient tests for triage and monitoring of disease...
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) saw a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 117,400 shares, a drop of 40.4% from the May 15th total of 197,100 shares. Approximately 1.2% of the shares of the company are sold short. Based on […]
Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and Beyond Air (NASDAQ:XAIR – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings. Institutional and Insider Ownership 45.4% of Bluejay Diagnostics shares […]
Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and INVO Bioscience (NASDAQ:INVO – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, profitability and institutional ownership. Profitability This table compares Bluejay Diagnostics and INVO Bioscience’s […]